| Title | Expert Opinion on Drug Discovery |
| Abbreviation | Expert Opin. Drug Discov. |
| Publication Type | Journal |
| Subject Area, Categories, Scope | Drug Discovery (Q1) |
| h-index | 77 |
| Overall Rank/Ranking | 3011 |
| SCImago Journal Rank (SJR) | 1.219 |
| Impact Score | 5.57 |
| Publisher | Informa Healthcare |
| Country | United Kingdom |
| ISSN | 1746045X, 17460441 |
| Best Quartile | Q1 |
| Coverage History | 2006-2022 |
Expert Opinion on Drug Discovery (ISSN 1746-0441 [print], 1746-045X [electronic]) is a peer-reviewed, international journal publishing review articles on novel technologies involved in the drug discovery process, leading to new leads and reduced attrition rates. Each article is structured to incorporate the author’s own expert opinion on the scope for future development.
Expert Opinion on Drug Discovery is a journal covering the technologies/fields/categories related to Drug Discovery (Q1). It is published by Informa Healthcare. The overall rank of Expert Opinion on Drug Discovery is 3011. According to SCImago Journal Rank (SJR), this journal is ranked 1.219. SCImago Journal Rank is an indicator, which measures the scientific influence of journals. It considers the number of citations received by a journal and the importance of the journals from where these citations come. SJR acts as an alternative to the Journal Impact Factor (or an average number of citations received in last 2 years). This journal has an h-index of 77. The best quartile for this journal is Q1.
The ISSN of Expert Opinion on Drug Discovery journal is 1746045X, 17460441. An International Standard Serial Number (ISSN) is a unique code of 8 digits. It is used for the recognition of journals, newspapers, periodicals, and magazines in all kind of forms, be it print-media or electronic. Expert Opinion on Drug Discovery is cited by a total of 2126 articles during the last 3 years (Preceding 2022).
The Impact IF 2022 of Expert Opinion on Drug Discovery is 5.57, which is computed in 2023 as per its definition. Expert Opinion on Drug Discovery IF is decreased by a factor of 0.12 and approximate percentage change is -2.11% when compared to preceding year 2021, which shows a falling trend. The impact IF, also denoted as Journal impact score (JIS), of an academic journal is a measure of the yearly average number of citations to recent articles published in that journal. It is based on Scopus data.
Impact IF 2022 of Expert Opinion on Drug Discovery is 5.57. If the same downward trend persists, Impact IF may fall in 2023 as well.
| Year | Impact IF |
|---|---|
| 2023/2024 | Coming Soon |
| 2022 | 5.57 |
| 2021 | 5.69 |
| 2020 | 4.67 |
| 2019 | 4.46 |
| 2018 | 4.09 |
| 2017 | 4.35 |
| 2016 | 3.67 |
| 2015 | 3.75 |
| 2014 | 3.77 |
Expert Opinion on Drug Discovery has an h-index of 77. It means 77 articles of this journal have more than 77 number of citations. The h-index is a way of measuring the productivity and citation impact of the publications. The h-index is defined as the maximum value of h such that the given journal/author has published h papers that have each been cited at least h number of times.
The ISSN of Expert Opinion on Drug Discovery is 1746045X, 17460441. ISSN stands for International Standard Serial Number.
An ISSN is a unique code of 8 digits. It is used for the recognition of journals, newspapers, periodicals, and magazines in all kind of forms, be it print-media or electronic.
The overall rank of Expert Opinion on Drug Discovery is 3011. According to SCImago Journal Rank (SJR), this journal is ranked 1.219. SCImago Journal Rank is an indicator, which measures the scientific influence of journals. It considers the number of citations received by a journal and the importance of the journals from where these citations come.
| Year | SJR |
|---|---|
| 2023/2024 | Coming Soon |
| 2022 | 1.219 |
| 2021 | 1.023 |
| 2020 | 1.316 |
| 2019 | 1.160 |
| 2018 | 1.450 |
| 2017 | 1.309 |
| 2016 | 1.116 |
| 2015 | 1.236 |
| 2014 | 1.154 |
| Year | Ranking |
|---|---|
| 2023/2024 | Coming Soon |
| 2022 | 3011 |
| 2021 | 3959 |
| 2020 | 2821 |
| 2019 | 3431 |
| 2018 | 2389 |
| 2017 | 2890 |
| 2016 | 3737 |
| 2015 | 3260 |
| 2014 | 3514 |
Expert Opinion on Drug Discovery is published by Informa Healthcare. It's publishing house is located in United Kingdom. Coverage history of this journal is as following: 2006-2022. The organization or individual who handles the printing and distribution of printed or digital publications is known as Publisher.
Visit the official website of the journal/conference to check the further details about the call for papers.
The IS0 4 standard abbreviation of Expert Opinion on Drug Discovery is Expert Opin. Drug Discov.. This abbreviation ('Expert Opin. Drug Discov.') is well recommended and approved for the purpose of indexing, abstraction, referencing and citing goals. It meets all the essential criteria of ISO 4 standard.
ISO 4 (International Organization for Standardization 4) is an international standard that defines a uniform and consistent system for abbreviating serial publication titles and journals.
If your research field is/are related to Drug Discovery (Q1), then please visit the official website of this journal.
The acceptance rate/percentage of any academic journal/conference depends upon many parameters. Some of the critical parameters are listed below.
It is essential to understand that the acceptance rate/rejection rate of papers varies among journals. Some Journals considers all the manuscripts submissions as a basis of acceptance rate computation. On the other hand, few consider the only manuscripts sent for peer review or few even not bother about the accurate maintenance of total submissions. Hence, it can provide a rough estimation only.
The best way to find out the acceptance rate is to reach out to the associated editor or to check the official website of the Journal/Conference.
Expert Opinion on Drug Discovery latest impact IF is 5.57. It's evaluated in the year 2022. The highest and the lowest impact IF or impact score of this journal are 5.69 (2021) and 3.67 (2016), respectively, in the last 9 years. Moreover, its average IS is 4.45 in the previous 9 years.
The Expert Opinion on Drug Discovery has an SJR (SCImago Journal Rank) of 1.219, according to the latest data. It is computed in the year 2023. In the past 9 years, this journal has recorded a range of SJR, with the highest being 1.450 in 2018 and the lowest being 1.023 in 2021. Furthermore, the average SJR of the Expert Opinion on Drug Discovery over the previous 9-year period stands at 4.45.
The latest h-index of the Expert Opinion on Drug Discovery is 77.
The Expert Opinion on Drug Discovery is published by the Informa Healthcare, with its country of publication being the United Kingdom.
The Expert Opinion on Drug Discovery is currently ranked 3011 out of 27955 Journals, Conferences, and Book Series in the latest ranking. Over the course of the last 9 years, this journal has experienced varying rankings, reaching its highest position of 2389 in 2018 and its lowest position of 3959 in 2021.
The standard ISO4 abbreviation for the Expert Opinion on Drug Discovery is Expert Opin. Drug Discov..
Expert Opinion on Drug Discovery is classified as a journal that the Informa Healthcare publishes.
The Expert Opinion on Drug Discovery encompasses the following areas:
For a more comprehensive understanding of its scope, check the official website of this journal.
The Expert Opinion on Drug Discovery is assigned the following International Standard Serial Numbers (ISSN): 1746045X, 17460441.
The best quartile for the Expert Opinion on Drug Discovery is Q1 (2022).
The Expert Opinion on Drug Discovery coverage history can be summarized as follows: 2006-2022.
| Journal/Conference/Workshop/Book Title | Type | Ranking | Publisher | h-index | Impact Score |
|---|---|---|---|---|---|
| IEEE/OSA Journal of Display Technology | journal | 12809 | IEEE Computer Society | 68 | 0.00 |
| CESifo Economic Studies | journal | 14012 | Oxford University Press | 32 | 1.70 |
| Mathematical Modelling and Analysis | journal | 11315 | Vilnius Gediminas Technical University | 27 | 1.75 |
| International Journal of Applied Linguistics | journal | 7321 | Wiley-Blackwell Publishing Ltd | 51 | 2.00 |
| International Journal of Parallel, Emergent and Distributed Systems | journal | 15843 | Taylor and Francis Ltd. | 23 | 1.28 |
| Modern Language Journal | journal | 918 | Wiley-Blackwell | 103 | 3.89 |
| Journal of Sociolinguistics | journal | 5409 | Wiley-Blackwell Publishing Ltd | 61 | 1.96 |
| Oral Radiology | journal | 9461 | Springer Japan | 20 | 2.06 |
| Journal of Immigrant and Refugee Studies | journal | 9246 | Routledge | 32 | 1.46 |
| Acta Periodica Technologica | journal | 19470 | University of Novi Sad, Faculty of Technology | 18 | 0.62 |
| Year | Impact Score (IS) |
|---|---|
| 2023/2024 | Coming Soon |
| 2022 | 5.57 |
| 2021 | 5.69 |
| 2020 | 4.67 |
| 2019 | 4.46 |
| 2018 | 4.09 |
| 2017 | 4.35 |
| 2016 | 3.67 |
| 2015 | 3.75 |
| 2014 | 3.77 |
